Recently, EAONO/JOS's joint consensus paper on definitions, classification, and staging of middle ear cholesteatoma was published 1 .
1. The borders of divisions of the middle ear and mastoid are further defined, and consequently, the figure of the consensus paper is refined [1] .
In the EAONO/JOS consensus statement, the middle ear and mastoid spaces are divided into four sites to classify the extent of the cholesteatoma: difficult access sites (S), tympanic cavity (T), attic (A), and mastoid and antrum (M). The difficult access sites (S) further include S1 (the supratubal recess) and S2 (the sinus tympani). We propose to define the anatomical divisions of the middle ear and mastoid in more detail using surgical and anatomical landmarks. These landmarks based on a selection of published papers on this topic are highly likely to be identified both on CT scans and during all types of surgical approaches and are thus less prone to various interpretations [2] [3] [4] . Table 1 summarizes our suggestions for further specification of borders between the different sites of the middle ear and mastoid. In addition, Figure 1 shows the updated illustration based on those refined borders.
A should be reported. In case a cholesteatoma extends anteriorly to the head of the malleus, S1 should be reported too. The head of the malleus is the most prominent landmark and likely to be visible on CT images with a microscope or endoscope. Further, the other borders are refined following this line of reasoning.
STAM system is elaborated to STAMCO by inclusion of the status of complications (C) and ossicular chain (O).
Classifications are designed to improve outcome comparison. One of the most important postoperative outcome measures is residual or recurrence of cholesteatoma, in which the location of the cholesteatoma will probably be the most important perioperative parameter. This is perfectly registered in the STAM system. Still, two other postoperative outcome measures, including complications and hearing, are not directly related to the perioperative extent of the cholesteatoma (STAM). As shown in Table 1 , we propose including the alphabetic character C for the presence of pre or perioperative complications. The consensus statement does take complications into account by directly staging them as stage III or IV, but by doing so, information on the perioperative extent of the disease is lost. It is yet to be determined whether the presence of a complication is related to worse postoperative outcome. By omitting the information on the extent of the disease, it may not be possible to demonstrate such a relationship. A better solution is to first implement a standard monitoring option of intracranial and/or extracranial complications, such as our intention with the letter C. It should be noted that cerebrospinal fluid leak (not mentioned in the consensus paper) may be considered an extracranial complication. Table 1 . STAMCO cholesteatoma classification system: registration of the extent of cholesteatoma (STAM), complications (C) and ossicular chain status (O) during surgery based on STAM system as presented by EAONO/JOS.
Letter Explanation
Further classified as To be defined by anatomical landmarks as S Difficult access sites S1: Difficult anterior area The area anterior/antero-inferior to one of the following: (anterior epitympanic space/supratubal recess)
• We also recommend the registration of the location of cholesteatoma as follows:
STAM3CO=3 or more locations, or one of the S locations involved Add "r" when a revision surgery in front is performed: rSTAMCO additionally suggested including the alphabetic character O for ossicular chain status in the classification during surgery [5] . The status of the ossicular chain is important to report because this represents the impact of the cholesteatoma, and certain ossicles are more important in hearing reconstruction. Extending the classification contributes to correlating hearing-related outcomes with the primary disease process [6] . The relevant aspects of existing classifications, as proposed in a recent review, are in our opinion better represented by the STAMCO system [7] .
To currently postpone staging.
Based on the extent of the cholesteatoma and on the presence of extracranial or intracranial complications, the EOANO/JOS consensus statement proposed to classify cholesteatoma into four stages [1] . This staging system implies a correlation between higher stage and worse outcome. As this correlation has yet to be demonstrated, it seems premature to currently implement this staging system. Therefore, we would like to propose the postponement of staging. In the future, when the classification system is widely implemented and has led to uniformity in reported case series, outcome data can be correlated to the classification. This can serve as the basis of a staging system. This is comparable to the way the internationally accepted TNM classification for malignant tumors has been implemented: first, the TNM classification by anatomical extent of the disease was adopted in 1952. After several years of research, outcomes were published and consensus meetings were held to stage the disease based on classification and outcome (for up-to-date version check www. uicc.org/resources/tnm).
All in all, we would like to acknowledge the European and Japanese societies for their effort and great work on the classification and staging of middle ear cholesteatoma. It is a big step forward, and we are keen on implementing the classification in our national cholesteatoma study. To facilitate its implementation as a national standard, we propose further refining the borders of divisions by anatomical landmarks and to modify the classification from STAM into STAM-CO (S: difficult access Sites; T: Tympanic cavity; A: Attic/epitympanic space; M: Mastoid and antrum; C: Complication status; O: Ossicular chain status). The EAONO/JOS classification and staging system is based on consensus rather than evidence. The staging system is designed to reflect the difficulty in cholesteatoma eradication. In theory, stage 1 disease should have a lower recurrent/residual rate than stage 2 or 3 disease. The value of the JOS staging system has already been published in a multi-center study [1] . There are other outcome parameters that are important for patients, such as dry ear rate, waterproofing rate, and hearing gain. Each of these is its own risk factors, e.g., dry ear and waterproofing are related to the cavity size in relation to the meatus size, postoperative hearing level is related to the ossicular status, mucosa status, and presence of otorrhoea at the time of surgery [2] . Designing a single staging system that will encompass all these outcome parameters can only be done by evolution, even if it is possible. It is for the similar reason that cancer staging in general is based on survival rate rather than a multitude of outcome parameters such as quality of life.
The EAONO/JOS steering group designs the current EAONO/JOS system to make it user-friendly and convenient. When surgeons audit their cholesteatoma surgery outcome data, they should include other parameters, such as age, primary vs. revision, mucosal status, ossicular status, reconstruction type, and hearing levels in addition to the EAONO/JOS classification and staging system. The advantage of the current EAONO/JOS staging system is that it is simple and intuitive as well as easy to use in conjunction with other parameters. For example, one can classify a cholesteatoma as occurring in the pars tensa, stage 2, M+I-S-. The proposed STAMCO appears to offer a code describing the extent of the cholesteatoma and ossicular status, rather than an alternative staging system. This is not in conflict with the current EAONO/JOS staging system. I welcome and encourage the 
